How much is CellCentric worth in 2026?

CellCentric has a current valuation of $382.5M based on their Later Stage VC round and secondary market data.

How much funding has CellCentric raised?

CellCentric has raised $280.5M in total funding across 2 funding rounds.

CellCentric

BiotechnologyWebsite

CellCentric valuation and funding history | Last updated: April 22, 2025 | 2 funding rounds

Current Valuation

$382.5M

As of April 22, 2025

Total Funding Raised

$280.5M

Across 2 rounds

Last Round

Later Stage VC

$116.5M

Last Funding

Apr 2025

Funding date

Capital Efficiency

1.36x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
April 22, 2025	Later Stage VC (Series C)	$116.5M	N/A	-
July 9, 2024	Later Stage VC (Series B)	$35.5M	N/A	-

Valuation Analysis

Current Valuation Metrics

CellCentric is currently valued at $382.5M as of April 22, 2025. The company has raised a total of $280.5M in funding across 2 funding rounds.

Capital Efficiency

With a capital efficiency ratio of 1.36x, CellCentric has achieved a valuation that is 1.36 times the total capital raised.

Track CellCentric Valuation Updates

Get notified when CellCentric raises new funding or valuation changes

Explore More Data

Detailed analysis for CellCentric

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock CellCentric's valuation history, funding rounds, and growth metrics.

No credit card required

What is CellCentric Worth in 2026?

CellCentric is a leading private company in the Biotechnology sector. Track CellCentric's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How CellCentric Valuation is Determined

Private company valuations like CellCentric's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.